RGEN
Repligen CorpCompany with tickers: RGEN
Market Cap
$7.81B
Shares Outstanding
56,407,740
CIK
730272
CUSIP
759916109
13F Activity (30d)
20 filings
10 filers
Website
Visit website
Investor Relations
Investor relations
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$25,000,000
as of 2023-12-31
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-02-26 | ||
| 2024-12-31 | $0 | 10-K, filed 2026-02-26 | ||
| 2023-12-31 | $14,386,000 | 10-K, filed 2026-02-26 | ||